Filing Flows › Edwards Lifesciences (EW) › Gross margin
Edwards Lifesciences (EW) gross margin by quarter
Edwards Lifesciences' gross margin was 78.5% in Q3 2026 (third quarter 2026), +1.0 pts from Q2 2026. Over the last 7 quarters it ranged from 77.5% (Q2 2026) to 78.7% (Q1 2025).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 78.5% | +1.0 pts | +0.7 pts |
| Q2 2026 | 77.5% | -0.5 pts | -0.1 pts |
| Q1 2026 | 78.0% | -0.1 pts | -0.6 pts |
| Q4 2025 | 78.1% | +0.4 pts | — |
| Q3 2025 | 77.8% | +0.3 pts | — |
| Q2 2025 | 77.5% | -1.1 pts | — |
| Q1 2025 | 78.7% | — | — |
Q3 2026 at a glance
Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.
Questions
What is Edwards Lifesciences' gross margin?
Edwards Lifesciences' gross margin was 78.5% in Q3 2026 (third quarter 2026), +1.0 pts from Q2 2026.
How has Edwards Lifesciences' gross margin changed?
Over the last 7 quarters it ranged from 77.5% (Q2 2026) to 78.7% (Q1 2025).